Hyperrab Injection
Product Images NDC 13533-618

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Hyperrab (NDC 13533-618). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Grifols Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Hyperrab S/d 10 mL Carton (Carton)

Label for HYPERRAB S/D Rabies Immune Globulin (Human) injection, 150 IU/mL strength, in a 10 mL vial. This plasma derivative is solvent/detergent treated, preservative-free, latex-free, and intended for intramuscular use. The label is from GRIFOLS USA, LLC, showing the NDC 13533-618-10 and includes storage instructions and usage warnings.*

FDA Label Image

Hyperrab S/d 10 mL Vial (Vial)

The label for HyperRAB S/D Rabies Immune Globulin (Human) injection, 150 IU/mL strength, in a 10 mL single dose vial. The product is solvent/detergent treated and manufactured by Grifols Therapeutics, LLC. It includes administration instructions noting intramuscular route only, dosage guideline of 20 IU/kg with rabies vaccine, and a caution not to give intravenously.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.